🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are now utilizing our technologies to develop mRNA and LNP-based treatments effective at the cell level. So if you're interested in doing transformative biomedical research for patients' lives, check out our new position and pass it along. jobs.helmholtz-muenchen.de/jobposting/a28…

A question that has long obsessed us: are the "seeds" of metastasis built into the primary tumor? In our new paper ,Shruthy Suresh (Aggarwal) tackled this question by combining human transcriptomics with the #Zebrafish TEAZ method to come up with the answer: doi.org/10.1158/2159-8…

Read our latest work on the power of CD4 T cells in cancer immunity: nature.com/articles/s4158…

A special thanks to our great collaborators including @OBechter and funders including the VIB grand challenge program VIB CCB_VIB_KUL Department of Oncology - KU Leuven FWO StichtingtegenKanker Melanoma Research

(Even a small amount of) CD4 T-cells can unleash a robust anti-tumour response through a rather unexpected mechanism…for more about this read this important paper from the Tüeting lab. Happy we could contribute to a small piece…

Ein interdisziplinäres Forscherteam der Universitätsmedizin Magdeburg entdeckt neuen Mechanismus der #Krebsimmunabwehr und liefert damit einen wichtigen Beitrag zur Verbesserung von #Krebs-#Immuntherapien. #TeamUMMD nature Mehr erfahren med.uni-magdeburg.de/News/Magdeburg…

My first first-author pub is finally out in Cancer Cell! Endless thanks to bizarMD Johannes Melms and Meri Rogava for all their guidance scientifically and personally that made this happen. Tweetorial below from our pre-print for now! authors.elsevier.com/c/1hFn35TA51da…

Australia - 1st authority in world to approve & fund #neoadjuvant pembrolizumab in resectable stage IIIB-D #melanoma. So proud of my co-med director @ProfRScolyerMIA - submitted with me on behalf Melanoma Institute Australia. Neoadjuvant clinical trials critical for zero deaths from #melanoma.

Thanks Cancer Cell for sharing, and grateful to reviewers and Montse Rojo de la Vega for a constructive, engaging and fair review/revision process. Hard work by Tricia Ho Johannes Melms Meri Rogava with a product we are proud of.

1/ We're thrilled to share our preprint on Deep3P - a new approach that takes us on a deep dive into the world of brain tumors, using three-photon microscopy and #AI. This exciting endeavor is brought to life together with the amazing Prevedel Lab ! tinyurl.com/mpz3extr

📢 Research Alert! 🧬🔬 🩺 We are super excited that our latest study, led by the great @RubenBill5 & Asa Wirapati, is out: science.org/doi/full/10.11… We set out to shed some light on the tumor microenvironment and its impact on cancer progression. 🧵

Proud to share our collaboration in the latest Cell paper led by Hanjie Li. The study presents an immune cell atlas & the dynamics of human macrophage specification in prenatal development. doi.org/10.1016/j.cell… (1/11)

Online Now: Interferon-stimulated neutrophils as a predictor of immunotherapy response dlvr.it/T10XST

We celebrate the 20th anniversary of our lab with a paper just out in the 50th anniversary special issue of Cell A great way to start 2024! A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma: Cell cell.com/cell/fulltext/…

Very excited to share new work from the lab dissecting mechanisms of liver-metastatic organotropism in melanoma and other cancers. Huge congrats to fearless post-doc Meri Rogava (on the job market!) who led this multi-year study! Below a brief summary... nature.com/articles/s4301…

Congratulations Matteo and co. for this beautiful study!

I feel very honored that the lab’s work has been awarded with the Georges-Köhler-Prize 🏆 from the German Society of Immunology DGfI - dgfi.org! Teamwork is essential to our work. Thanks to the whole team, its talented current and past members, & our fantastic collaboration partners!

Thanks for the shoutout!

We were priviliged to write a News & Views article on the fantaststic work by the group of Anja Obenauf that was published online in Nature Nov 27th (Elewaut et al. doi.org/10.1038/s41586…).  You can read it online with this SharedIt link: rdcu.be/d3cRz

This is the article Nature News & Views: A tumour-cell lipid reprograms immune cells doi.org/10.1038/d41586…